Autism-Spectrum DisorderNCT04324099
Investigating the Specificity of Neural Correlates for Emotion Processing Deficits in Conduct Disorder and Autism Spectrum Disorders
An observational study of Autism-Spectrum Disorder and Conduct Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
This study is 1. to investigate the differential and shared neural underpinnings of facial emotion processing within Conduct disorder (CD) and Autism-Spectrum disorder (ASD) and 2. to investigate the interaction between deficits in emotion processing and dysfunctional cognitive control processes. Read more about this study
- Who is it for?
- Ages 10 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Autism-Spectrum Disorder, Conduct Disorder
- What is being tested?
- neuroimaging session (with simultaneously acquired eye-tracking), Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)) and Social and Health Assessment (SAHA) questionnaire (for children)
- How many people
- 120 participants
- Where
- 1 siteSwitzerland
- Study dates
- 16 Jul 2020to Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: German speaking children and adolescents (10-18 years of age) attended at the Kinder- und Jugendpsychiatrischen Klinik Basel (KJPK) and with a confirmed diagnosis of CD or ASD. Typically developing children will be recruited using leaflets (will be distributed in the KJPK clinics and in socioeconomically diversesecondary schools within the Canton of Basel-Stadt).
Who may be able to join
- For all participants: age between 10 and 18 years and an intelligence quotient score of 70 or higher.
- For patient groups: confirmed clinical diagnoses according to Diagnostic and Statistical Manual (DSM)-5 of CD or ASD (depending on the group), without comorbid depression or anxiety psychological disorders.
Who cannot join
- For all participants: low intelligence (IQ<70, as they might otherwise not fully understand what they are expected to do inside the scanner), insufficient German language skills or any contraindications for MRI (e.g. pregnancy, any non-removable metal within the subjects' body, claustrophobia).
- For patient groups: severe developmental disorders, comorbid depressive and/or anxiety disorders will also be excluded from the study since it was shown that these patients might have problems in attention allocation under emotional stimulation.
- For typically developing participants: suspicion of an undiagnosed clinical disorder
Trial locations and contacts
1 site in 1 country.
Switzerland1 site, 1 recruiting
- Recruiting
Department of Child and Adolescent Psychiatry, KJPK (UPK)
Basel, 4002
Christina Stadler, Prof. Dr. med, +41 61 325 51 11, christina.stadler@upk.ch
About this study
This study is
- to investigate the differential and shared neural underpinnings of facial emotion processing within Conduct disorder (CD) and Autism-Spectrum disorder (ASD) and
- to investigate the interaction between deficits in emotion processing and dysfunctional cognitive control processes.
Differences in emotion processing and the underlying neural underpinnings of such differences will be assessed by means of functional magnetic resonance imaging (fMRI) without any contrast agent, combined with adapted emotion processing paradigms and eye tracking techniques.
- Conditions
- Autism-Spectrum Disorder, Conduct Disorder
- Being tested
- neuroimaging session (with simultaneously acquired eye-tracking), Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)), Social and Health Assessment (SAHA) questionnaire (for children), Massachusetts Youth Screening Instrument (MAYSI-2) (for children), Interpersonal Reactivity Index (IRI) (for children)
- Keywords
- Callous-Unemotional traits, emotion processing deficits, dysfunctional cognitive control processes
- Medical subject headings
- Child Development Disorders, Pervasive, Conduct Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
neuroimaging session (with simultaneously acquired eye-tracking)Other
neuroimaging session, including two functional neuroimaging paradigms (ca. 15-20 minutes each) and a short structural image acquisition (mprage) for coregistration. Functional Magnetic Brain Imaging (fMRI) and simultaneous eye-tracking data will be collected during the paradigms: 1) an emotion processing paradigm (adapted from Passamonti et al., 2010); and 2) an emotional Go/noGo paradigm (adapted from Hare et al., 2008).
Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ))Other
The Childhood Trauma Questionnaire is a brief survey of six early traumatic experiences (death, divorce, violence, sexual abuse, illness or other), and assesses individual's understanding of their childhood trauma.
Social and Health Assessment (SAHA) questionnaire (for children)Other
Self reported survey assessing social and mental health with four aspects of parenting determined (parental involvement, parental warmth, parental control, and inconsistency of parenting).
Massachusetts Youth Screening Instrument (MAYSI-2) (for children)Other
The Massachusetts Youth Screening Instrument (MAYSI-2) is a screening instrument developed for detecting mental health needs in youth aged 12-17. Designed as a low-cost, easily administered tool, it screens for multiple issues and can be administered in 10-15 minutes. It is divided into seven scales composed of 52 questions that are designed to detect alcohol/drug use, angryirritable behavior, depression-anxiety, somatic complaints, suicide ideation, thought disturbance, and traumatic experience. Youths answer YES or NO concerning whether each item has been true for them "within the past few months.
Interpersonal Reactivity Index (IRI) (for children)Other
The Interpersonal Reactivity Index is a measure of dispositional empathy that takes as its starting point the notion that empathy consists of a set of separate but related constructs. The instrument contains four seven-item subscales (seven Likert items each), each tapping a separate facet of empathy (Empathic Concern, Perspective Taking, Personal Distress, and Fantasy). The 28-item IRI contains four subscales
Youth Psychopathic Traits Inventory (YPI) (for children)Other
self-report screening measures to assess psychopathic traits in youth assessing 10 core personality traits associated with the construct (grandiosity, lying, manipulation, callousness, unemotionality, impulsivity, irresponsibility, dishonest charm, remorselessness, and thrill seeking). Each item is scored on an ordinal 4-point Likert scale (1 = Does not apply at all, to 4 = Applies very well). Higher scores reflect an increased presence of psychopathic traits.
Reactive Proactive Questionnaire (RPQ) (for children)Other
The Reactive-Proactive Questionnaire (RPQ) scores (0 (never), 1 sometimes, 2 (often)) for proactive aggression items and reactive items. Proactive and reactive scale scores are summated to obtain total aggression scores.
Emotion Regulation Questionnaire (for children)Other
10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree)
Basic Empathy Scale (BES) (for children)Other
The Basic Empathy Scale (BES) measures 20 items (affective and cognitive empathy) on a Five-point Likert-type scale.
Pubertal Development Scale (PDS) (for children)Other
self-report measure of physical development which has been shown to be correlated with measures of pubertal development derived from physical examination. Responses are coded on 4-point scales (1 = no development and 4 = completed development). For girls, a yes-no question about onset of menarche is weighted more heavily (1 = no and 4 = yes). For both genders, ratings are then averaged to create an overall score for physical maturation.
Alabama Parenting Questionnaire (APQ) (for parents)Other
The APQ measures five dimensions of parenting that are relevant to the etiology and treatment of child externalizing problems: (1) positive involvement with children, (2) supervision and monitoring, (3) use of positive discipline techniques, (4) consistency in the use of such discipline and (5) use of corporal punishment (42 self-reported responses, rated on a 5-point Likert scale- 1 (never) to 5 (always) for both child and parent forms)
Inventory of Callous Unemotional Traits (ICU) (for parents)Other
24-item questionnaire designed to provide a comprehensive assessment of callous and unemotional traits.The ICU has three subscales: Callousness, Uncaring, and Unemotional. The ICU is made up of statements with a 4-point Likert scale, ranging from 0 (Not at all true) to 3 (Definitely True), with higher scores indicating greater CU traits.
Child Behavior Checklist (CBCL) (for parents)Other
The eight empirically-based syndrome scales are:
- Aggressive Behavior
- Anxious/Depressed
- Attention Problems
- Rule-Breaking Behavior
- Somatic Complaints
- Social Problems
- Thought Problems
- Withdrawn/Depressed. Higher scores indicate greater Problems.
Griffith Empathy Measure (GEM) (for parents)Other
self-report 23-item measure of empathy in which the respondent answers each item on a nine-point Likert scale from strongly disagree to strongly agree
Social Responsiveness Scale (SRS) (for parents)Other
Social Responsiveness Scale (SRS) measures social ability of children from 4 years to 18 years old. It is used primarily with individuals with Autism Spectrum Disorder (ASD), family members of individuals with ASD, and others who have social impairments. Parent or teacher questionnaire (65 items on a 4-point Likert scale). High scores are associated with more severe social impairments.
| Study group | Role | What they receive |
|---|---|---|
| Conduct disorder | children and adolescents with CD Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents) | |
| Autism-Spectrum disorder | children and adolescents with ASD Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents) | |
| typically developing adolescents | typically developing adolescents Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents) |
What is being measured
The primary outcome is the main question the study is designed to answer.
difference between groups (children and adolescents with CD, ASD and typically developing adolescents) in neural activity
difference between groups in neural activity as measured by Blood Oxygen Level Dependent (BOLD) signal during emotion processing using a priori defined regions of interest (ROIs) including the insula, amygdala, and ventromedial prefrontal Cortex in fMRI
Measured: fMRI imaging Day 1
Secondary outcomes (1)
Emotion processing task (fMRI)
Emotion processing task (fMRI): measures of eye gaze collected by eye-tracking
Measured: fMRI imaging Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Mar 2020
- Study start16 Jul 2020
- Primary completionApr 2023 (estimated)
- Study completionJun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism-Spectrum DisorderStudies of the same condition, open and under way.
- More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Collaborators
- Swiss National Science Foundation
- Responsible party
- Sponsor
- Investigators
- Christina Stadler, Prof. Dr. med, Principal investigator, Department of Child and Adolescent Psychiatry, KJPK (UPK)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04324099
- Sponsor's protocol ID
- 2019-02386;pk17Stadler
- Other IDs
- 2019
- Status last verified
- Feb 2022
- First submitted
- 24 Mar 2020
- Last updated
- 2 Mar 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Mar 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigating the Specificity of Neural Correlates for Emotion Processing Deficits in Conduct Disorder and Autism Spectrum Disorders
- ClinicalTrials.gov ID
- NCT04324099
- Acronym / sponsor ID
- 2019-02386;pk17Stadler
- Conditions
- Autism-Spectrum Disorder, Conduct Disorder
- Keywords
- Callous-Unemotional traits, emotion processing deficits, dysfunctional cognitive control processes
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Collaborators
- Swiss National Science Foundation
- Study start
- 16 Jul 2020 (actual)
- Primary completion
- Apr 2023 (estimated)
- Study completion
- Jun 2023 (estimated)
- First posted
- 27 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is
- to investigate the differential and shared neural underpinnings of facial emotion processing within Conduct disorder (CD) and Autism-Spectrum disorder (ASD) and
- to investigate the interaction between deficits in emotion processing and dysfunctional cognitive control processes.
Differences in emotion processing and the underlying neural underpinnings of such differences will be assessed by means of functional magnetic resonance imaging (fMRI) without any contrast agent, combined with adapted emotion processing paradigms and eye tracking techniques.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Conduct disorder | – | Other: neuroimaging session (with simultaneously acquired eye-tracking), Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)), Other: Social and Health Assessment (SAHA) questionnaire (for children), Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children), Other: Interpersonal Reactivity Index (IRI) (for children), Other: Youth Psychopathic Traits Inventory (YPI) (for children), Other: Reactive Proactive Questionnaire (RPQ) (for children), Other: Emotion Regulation Questionnaire (for children), Other: Basic Empathy Scale (BES) (for children), Other: Pubertal Development Scale (PDS) (for children), Other: Alabama Parenting Questionnaire (APQ) (for parents), Other: Inventory of Callous Unemotional Traits (ICU) (for parents), Other: Child Behavior Checklist (CBCL) (for parents), Other: Griffith Empathy Measure (GEM) (for parents), Other: Social Responsiveness Scale (SRS) (for parents)children and adolescents with CD |
| Autism-Spectrum disorder | – | Other: neuroimaging session (with simultaneously acquired eye-tracking), Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)), Other: Social and Health Assessment (SAHA) questionnaire (for children), Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children), Other: Interpersonal Reactivity Index (IRI) (for children), Other: Youth Psychopathic Traits Inventory (YPI) (for children), Other: Reactive Proactive Questionnaire (RPQ) (for children), Other: Emotion Regulation Questionnaire (for children), Other: Basic Empathy Scale (BES) (for children), Other: Pubertal Development Scale (PDS) (for children), Other: Alabama Parenting Questionnaire (APQ) (for parents), Other: Inventory of Callous Unemotional Traits (ICU) (for parents), Other: Child Behavior Checklist (CBCL) (for parents), Other: Griffith Empathy Measure (GEM) (for parents), Other: Social Responsiveness Scale (SRS) (for parents)children and adolescents with ASD |
| typically developing adolescents | – | Other: neuroimaging session (with simultaneously acquired eye-tracking), Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)), Other: Social and Health Assessment (SAHA) questionnaire (for children), Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children), Other: Interpersonal Reactivity Index (IRI) (for children), Other: Youth Psychopathic Traits Inventory (YPI) (for children), Other: Reactive Proactive Questionnaire (RPQ) (for children), Other: Emotion Regulation Questionnaire (for children), Other: Basic Empathy Scale (BES) (for children), Other: Pubertal Development Scale (PDS) (for children), Other: Alabama Parenting Questionnaire (APQ) (for parents), Other: Inventory of Callous Unemotional Traits (ICU) (for parents), Other: Child Behavior Checklist (CBCL) (for parents), Other: Griffith Empathy Measure (GEM) (for parents), Other: Social Responsiveness Scale (SRS) (for parents)typically developing adolescents |
Who may qualify
- Ages
- 10 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- German speaking children and adolescents (10-18 years of age) attended at the Kinder- und Jugendpsychiatrischen Klinik Basel (KJPK) and with a confirmed diagnosis of CD or ASD. Typically developing children will be recruited using leaflets (will be distributed in the KJPK clinics and in socioeconomically diversesecondary schools within the Canton of Basel-Stadt).
Key inclusion criteria (2 listed)
- For all participants: age between 10 and 18 years and an intelligence quotient score of 70 or higher.
- For patient groups: confirmed clinical diagnoses according to Diagnostic and Statistical Manual (DSM)-5 of CD or ASD (depending on the group), without comorbid depression or anxiety psychological disorders.
Key exclusion criteria (3 listed)
- For all participants: low intelligence (IQ<70, as they might otherwise not fully understand what they are expected to do inside the scanner), insufficient German language skills or any contraindications for MRI (e.g. pregnancy, any non-removable metal within the subjects' body, claustrophobia).
- For patient groups: severe developmental disorders, comorbid depressive and/or anxiety disorders will also be excluded from the study since it was shown that these patients might have problems in attention allocation under emotional stimulation.
- For typically developing participants: suspicion of an undiagnosed clinical disorder
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| neuroimaging session (with simultaneously acquired eye-tracking)neuroimaging session, including two functional neuroimaging paradigms (ca. 15-20 minutes each) and a short structural image acquisition (mprage) for coregistration. Functional Magnetic Brain Imaging (fMRI) and simultaneous eye-tracking data will be collected during the paradigms: 1) an emotion processing paradigm (adapted from Passamonti et al., 2010); and 2) an emotional Go/noGo paradigm (adapted from Hare et al., 2008). | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ))The Childhood Trauma Questionnaire is a brief survey of six early traumatic experiences (death, divorce, violence, sexual abuse, illness or other), and assesses individual's understanding of their childhood trauma. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Social and Health Assessment (SAHA) questionnaire (for children)Self reported survey assessing social and mental health with four aspects of parenting determined (parental involvement, parental warmth, parental control, and inconsistency of parenting). | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Massachusetts Youth Screening Instrument (MAYSI-2) (for children)The Massachusetts Youth Screening Instrument (MAYSI-2) is a screening instrument developed for detecting mental health needs in youth aged 12-17. Designed as a low-cost, easily administered tool, it screens for multiple issues and can be administered in 10-15 minutes. It is divided into seven scales composed of 52 questions that are designed to detect alcohol/drug use, angryirritable behavior, depression-anxiety, somatic complaints, suicide ideation, thought disturbance, and traumatic experience. Youths answer YES or NO concerning whether each item has been true for them "within the past few months. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Interpersonal Reactivity Index (IRI) (for children)The Interpersonal Reactivity Index is a measure of dispositional empathy that takes as its starting point the notion that empathy consists of a set of separate but related constructs. The instrument contains four seven-item subscales (seven Likert items each), each tapping a separate facet of empathy (Empathic Concern, Perspective Taking, Personal Distress, and Fantasy). The 28-item IRI contains four subscales | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Youth Psychopathic Traits Inventory (YPI) (for children)self-report screening measures to assess psychopathic traits in youth assessing 10 core personality traits associated with the construct (grandiosity, lying, manipulation, callousness, unemotionality, impulsivity, irresponsibility, dishonest charm, remorselessness, and thrill seeking). Each item is scored on an ordinal 4-point Likert scale (1 = Does not apply at all, to 4 = Applies very well). Higher scores reflect an increased presence of psychopathic traits. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Reactive Proactive Questionnaire (RPQ) (for children)The Reactive-Proactive Questionnaire (RPQ) scores (0 (never), 1 sometimes, 2 (often)) for proactive aggression items and reactive items. Proactive and reactive scale scores are summated to obtain total aggression scores. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Emotion Regulation Questionnaire (for children)10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree) | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Basic Empathy Scale (BES) (for children)The Basic Empathy Scale (BES) measures 20 items (affective and cognitive empathy) on a Five-point Likert-type scale. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Pubertal Development Scale (PDS) (for children)self-report measure of physical development which has been shown to be correlated with measures of pubertal development derived from physical examination. Responses are coded on 4-point scales (1 = no development and 4 = completed development). For girls, a yes-no question about onset of menarche is weighted more heavily (1 = no and 4 = yes). For both genders, ratings are then averaged to create an overall score for physical maturation. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Alabama Parenting Questionnaire (APQ) (for parents)The APQ measures five dimensions of parenting that are relevant to the etiology and treatment of child externalizing problems: (1) positive involvement with children, (2) supervision and monitoring, (3) use of positive discipline techniques, (4) consistency in the use of such discipline and (5) use of corporal punishment (42 self-reported responses, rated on a 5-point Likert scale- 1 (never) to 5 (always) for both child and parent forms) | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Inventory of Callous Unemotional Traits (ICU) (for parents)24-item questionnaire designed to provide a comprehensive assessment of callous and unemotional traits.The ICU has three subscales: Callousness, Uncaring, and Unemotional. The ICU is made up of statements with a 4-point Likert scale, ranging from 0 (Not at all true) to 3 (Definitely True), with higher scores indicating greater CU traits. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Child Behavior Checklist (CBCL) (for parents)The eight empirically-based syndrome scales are: 1. Aggressive Behavior 2. Anxious/Depressed 3. Attention Problems 4. Rule-Breaking Behavior 5. Somatic Complaints 6. Social Problems 7. Thought Problems 8. Withdrawn/Depressed. Higher scores indicate greater Problems. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Griffith Empathy Measure (GEM) (for parents)self-report 23-item measure of empathy in which the respondent answers each item on a nine-point Likert scale from strongly disagree to strongly agree | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
| Social Responsiveness Scale (SRS) (for parents)Social Responsiveness Scale (SRS) measures social ability of children from 4 years to 18 years old. It is used primarily with individuals with Autism Spectrum Disorder (ASD), family members of individuals with ASD, and others who have social impairments. Parent or teacher questionnaire (65 items on a 4-point Likert scale). High scores are associated with more severe social impairments. | Other | Autism-Spectrum disorder, Conduct disorder, typically developing adolescents |
Primary outcome
difference between groups (children and adolescents with CD, ASD and typically developing adolescents) in neural activity
Time frame: fMRI imaging Day 1
difference between groups in neural activity as measured by Blood Oxygen Level Dependent (BOLD) signal during emotion processing using a priori defined regions of interest (ROIs) including the insula, amygdala, and ventromedial prefrontal Cortex in fMRI
1 secondary outcome
Emotion processing task (fMRI)
Time frame: fMRI imaging Day 1
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Mar 2022.
Related trials for Autism-Spectrum Disorder
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
Transcranial Direct Current Stimulation, Autistic Spectrum Disorder
Not yet recruiting
"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial
Autism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christina Stadler, Prof. Dr. med principal investigator
Department of Child and Adolescent Psychiatry, KJPK (UPK)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Autism-Spectrum Disorder and Conduct Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Christina Stadler, Prof. Dr. med (+41 61 325 51 11, christina.stadler@upk.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
difference between groups (children and adolescents with CD, ASD and typically developing adolescents) in neural activity (time frame: fMRI imaging Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2022.